ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)

Tuesday, February 16th, 2010

ExonHit Therapeutics hopes to commercialize a microarray-based clinical test for diagnosing Alzheimer’s disease in Europe by the first quarter of next year, the company said this week.

More:
ExonHit Preps Affy-Based Alzheimer’s Test for 2011 Launch (GenomeWeb News)

Tags: ... continue reading